Back
Desjardins Absolute Return Glb Eq Mkts ETF USD Hg Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
36
DAMG.U.TO
Desjardins Absolute Return Glb Eq Mkts ETF USD Hg
Last Price:
$21.07
Seasonality Move:
0.53%
Buy
90
KYMR
Kymera Therapeutics, Inc.
Last Price:
$94.38
Seasonality Move:
7.7%
Sell
36
Desjardins Absolute Return Glb Eq Mkts ETF USD Hg (DAMG.U.TO)
is a Sell
Is Desjardins Absolute Return Glb Eq Mkts ETF USD Hg a Buy, Sell or Hold?
-
The current Desjardins Absolute Return Glb Eq Mkts ETF USD Hg [DAMG.U.TO] share price is $21.10. The Score for DAMG.U.TO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
DAMG.U.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
90
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $94.30. The Score for KYMR is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
DAMG.U.TO Stock Price Chart
What is Desjardins Absolute Return Glb Eq Mkts ETF USD Hg's stock price today?
-
The Desjardins Absolute Return Glb Eq Mkts ETF USD Hg share price today is $21.10The current trend is moderately bearish and DAMG.U.TO is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $94.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
DAMG.U.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 49.29 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.95 - 21.31) | Sell |
| Bollinger Bands (100): | (21.06 - 21.44) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 86.88 | Buy |
| Chaikin Money Flow: | -462379 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.8 - 71.72) | Buy |
| Bollinger Bands (100): | (43.38 - 63.26) | Buy |
DAMG.U.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.08 | Buy |
| 20-day SMA: | 21.06 | Buy |
| 50-day SMA: | 21.22 | Sell |
| 200-day SMA: | 20.96 | Buy |
| 8-day EMA: | 21.07 | Buy |
| 20-day EMA: | 21.09 | Buy |
| 50-day EMA: | 20.62 | Buy |
| 200-day EMA: | 12.7 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70 | Buy |
| 20-day SMA: | 66.61 | Buy |
| 50-day SMA: | 61.97 | Buy |
| 200-day SMA: | 44.25 | Buy |
| 8-day EMA: | 72.36 | Buy |
| 20-day EMA: | 67.57 | Buy |
| 50-day EMA: | 61.93 | Buy |
| 200-day EMA: | 49.42 | Buy |
Desjardins Absolute Return Glb Eq Mkts ETF USD Hg Earnings Growth & DAMG.U.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
Desjardins Absolute Return Glb Eq Mkts ETF USD Hg Technical Analysis
| Nov 25 | Nov 26 | Nov 27 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 27 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||